Skip to content

Clinical trials

Hematologic Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Country / region: Brazil Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20173
20192
20202
20214
20224
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7
Completed5
Recruiting2
Terminated2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
BioMarin Pharmaceutical4
Loxo Oncology, Inc.3
Novartis Pharmaceuticals2
University of Sao Paulo2
Cellectar Biosciences, Inc.1
Hospital Israelita Albert Einstein1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases19
Anemia, Sickle Cell5
Hemophilia A5
Hemorrhagic Disorders5
Vaso-Occlusive Crises5
Blood Coagulation Disorders4
Blood Coagulation Disorders, Inherited4
Coagulation Protein Disorders4
Genetic Diseases, Inborn4
Hemostatic Disorders4

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.